| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +37% |
| 3Y CAGR | +226% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +448% |
| 3Y CAGR | +78% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹19,700.00 +420.00 (2.18%) | 24,730.83 | 49.68 | 13.2 | ||
Cohance LifesciencesCOHANCE | ₹444.30 -37.05 (7.70%) | 18,416.32 | 314.61 | 4.71 | ||
Syngene InternationalSYNGENE | ₹402.70 +4.10 (1.03%) | 16,078.14 | 86.4 | 3.31 | ||
₹731.70 -9.35 (1.26%) | 11,664.47 | 39.84 | 3.52 |